- £710.70m
- £476.84m
- £812.42m
- 94
- 97
- 25
- 86
R2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 35.7 | 251 | 126 | 514 | 812 |
Cost of Revenue | |||||
Gross Profit | 20 | 85.8 | -2.92 | 387 | 594 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | -3.85 | 163 | 144 | 268 | 336 |
Operating Profit | 39.6 | 87.7 | -18.7 | 246 | 476 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 39.5 | 109 | 12.5 | 135 | 488 |
Provision for Income Taxes | |||||
Net Income After Taxes | 51.5 | 64 | 7.78 | 79.3 | 178 |
Net Income Before Extraordinary Items | |||||
Net Income | 51.5 | 64 | 7.78 | 79.3 | 178 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 51.5 | 64 | 7.78 | 79.3 | 178 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.11 | 0.232 | 0.028 | 0.282 | 0.803 |
Dividends per Share |